Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction

2006 ◽  
Vol 68 (3) ◽  
pp. 392-398 ◽  
Author(s):  
Giuseppe Gioia ◽  
William Matthai ◽  
Alberto Benassi ◽  
Hamza Rana ◽  
Howard A. Levite ◽  
...  
Keyword(s):  
Left Ventricular Dysfunction ◽  
Stent Implantation ◽  
Ventricular Dysfunction ◽  
Bare Metal Stent ◽  
Left Ventricular ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Severe Left Ventricular Dysfunction ◽  
Drug Eluting

scholarly journals Clinical outcomes after the endovascular treatments of pulmonary vein stenosis in patients with congenital heart disease

2019 ◽  
Vol 29 (8) ◽  
pp. 1057-1065 ◽  
Author(s):  
Yoshihiko Kurita ◽  
Kenji Baba ◽  
Maiko Kondo ◽  
Takahiro Eitoku ◽  
Shingo Kasahara ◽  
...  
Keyword(s):  
Pulmonary Vein ◽  
Stent Implantation ◽  
Bare Metal Stent ◽  
Pulmonary Vein Stenosis ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Significant Difference ◽  
Drug Eluting ◽  
Vein Stenosis

AbstractBackground:Pulmonary vein stenosis (PVS) is a condition with challenging treatment and leads to severe cardiac failure and pulmonary hypertension. Despite aggressive surgical or catheter-based intervention, the prognosis of PVS is unsatisfactory. This study aimed to assess the prognosis and to establish appropriate treatment strategies.Methods:We retrospectively reviewed endovascular treatments for PVS (2001–2017) from the clinical database at the Okayama University Hospital.Results:A total of 24 patients underwent PVS associated with total anomalous pulmonary venous connection and 7 patients underwent isolated congenital PVS. In total, 53 stenotic pulmonary veins were subjected to endovascular treatments; 40 of them were stented by hybrid (29) and percutaneous procedures (11) (bare-metal stent, n = 34; drug-eluting stent, n = 9). Stent size of hybrid stenting was larger than percutaneous stenting. Median follow-up duration from the onset of PVS was 24 months (4–134 months). Survival rate was 71 and 49% at 1 and 5 years, respectively. There was no statistically significant difference between stent placement and survival; however, patients who underwent bare-metal stent implantation had statistically better survival than those who underwent drug-eluting stent implantation or balloon angioplasty. Early onset of stenosis, timing of stenting, and small vessel diameter of pulmonary vein before stenting were considered as risk factors for in-stent restenosis. Freedom from re-intervention was 50 and 26% at 1 and 2 years.Conclusions:To improve survival and stent patency, implantation of large stent is important. However, re-intervention after stenting is also significant to obtain good outcome.

scholarly journals Bare metal stent implantation for in-stent restenosis with a drug-eluting stent

2010 ◽  
Vol 55 (1) ◽  
pp. 135-138 ◽  
Author(s):  
Hiroshi Matsuoka ◽  
Hideo Kawakami ◽  
Akira Ohshita ◽  
Tamami Kohno ◽  
Susumu Shigemi ◽  
...  
Keyword(s):  
Stent Implantation ◽  
Bare Metal Stent ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Stent Restenosis ◽  
Drug Eluting ◽  
In Stent Restenosis
Sign in / Sign up

Export Citation Format

Share Document